Why Baltimore Is Emerging as the Next Great City for Medtech

Published on : Published by : Chris Frew

Baltimore, MD is continuing to emerge as one of the next great cities for medtech and medical device innovation. That’s just one of the reasons that Maryland was selected to host MedTech Innovator  (MTI) and BioTools Innovator (BTI) for their East Coast pitch events on March 28-31, 2023. MTI and BTI are the largest and highest-performing global pitch competitions and accelerator programs for the life sciences field. Companies can apply before January 31st.

City Garage Science and Technology Center Signs Leases with Haystack Oncology and Longeviti Neuro Solutions and an Expansion with Launchport

Photo of City Garage in Baltimore
Published on : Published by : BioBuzz Media

Haystack Oncology and Longeviti Neuro Solutions, life science companies affiliated with Johns Hopkins University, have signed leases at City Garage Science and Technology Center totaling over 30,000 square feet in Baltimore Peninsula. Additionally, Launchport has expanded their operations by 6,200-sf.

FDA Grants Clearance for Longeviti’s Off-The-Shelf ClearFit® Cover, Accelerating Capability of Ultrasound Imaging after Complex Brain Surgery

Longeviti logo
Published on : Published by : BioBuzz Media

Longeviti Neuro Solutions, developer of the first low-profile intracranial devices that meets the functional and reconstructive needs of brain surgery patients, recently announced that it was granted a 510(k) clearance by the U.S Food and Drug Administration (FDA) for ClearFit® OTS (off-the-shelf).

Longeviti Welcomes Renowned Neurosurgeon, Leading Cerebral Expert, Dr. David Langer as New Chief Medical Officer

Published on : Published by : BioBuzz Media

Longeviti Neuro Solutions, developer of the first low-profile intracranial devices that meet the functional and reconstructive needs of brain surgery patients, has hired Dr. David Langer as chief medical officer.  With more than 22 years of experience in highly personalized direct patient care and expertise in medical technology, Dr. Langer will develop and drive the clinical strategy to expand use of Longeviti’s innovative solutions for patients undergoing complex brain surgery.